NCT02451735

Brief Summary

The purpose of this study is to review and evaluate the effectiveness of new educational materials (informational booklet \& DVD) that promote participation in genetic counseling among breast cancer survivors. There are two phases to this study: Part 1 - reviewing the newly developed educational materials, and Part 2 - evaluating the effectiveness of the newly developed educational materials

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Jul 2012

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 27, 2012

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

May 18, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 22, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2016

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2019

Completed
Last Updated

November 8, 2019

Status Verified

November 1, 2019

Enrollment Period

4 years

First QC Date

May 18, 2015

Last Update Submit

November 6, 2019

Conditions

Keywords

female breast cancerbilateral breast cancertriple negative breast cancerbreast cancer diagnosisBRCA 1BRCA 2psychoeducational intervention (PEI)genetic counselinghereditary breast and ovarian cancer (HBOC)cancer education materials

Outcome Measures

Primary Outcomes (2)

  • Part 1: Rate of Initial Survey Responses

    Intervention Development: Rate of feedback of draft materials required to complete a formative evaluation.

    Up to 8 months

  • Part 2: Rate of Participation

    Participation in the Psychoeducational Intervention (PEI) group compared to the Factsheet group.

    Up to 8 months

Secondary Outcomes (1)

  • Rate of Impact

    Up to 8 months

Study Arms (3)

Intervention Development

NO INTERVENTION

Psychoeducational Intervention (PEI) development. PEIs include printed and DVD materials, and represent a commonly used and effective approach to implement theoretically based individual-level interventions. These materials serve as important sources of information for the general public, cancer patients, and survivors from a variety of backgrounds, including populations with limited health literacy. An interview and feedback collection process will take place to provide data to improve current PEI materials.

Intervention Pilot - Intervention Group

EXPERIMENTAL

The intervention group will receive the PEI materials: video and booklet. Self-reported feedback will be collected and reviewed to compare response with the control group.

Behavioral: Video and Booklet

Intervention Pilot - Control Group

ACTIVE COMPARATOR

The control group will receive a patient factsheet about Genetic Counseling (GC). Self-reported feedback will be collected and reviewed to compare response with the intervention group.

Behavioral: Factsheet

Interventions

Printed and DVD materials about Genetic Counseling. Self-reported feedback will be collected and reviewed to compare to the control group response.

Intervention Pilot - Intervention Group
FactsheetBEHAVIORAL

Patient factsheet about Genetic Counseling. Self-reported feedback will be collected and reviewed to compare to the intervention group response.

Intervention Pilot - Control Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Part 1: Female breast cancer patients at Moffitt Cancer Center (MCC) are eligible to participate if they:
  • are \> 18 years of age;
  • have no documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis);
  • are capable of speaking and reading standard English;
  • have not attended or scheduled an upcoming appointment for genetic counseling at the time of recruitment;
  • are within 18 months of their breast cancer (BC) diagnosis;
  • have a previous diagnosis of breast cancer or;
  • received a referral letter for GC from their MCC physician;
  • breast cancer at age 50 or below;
  • bilateral breast cancer;
  • multiple cancers except basal cell carcinoma;
  • triple negative breast cancer;
  • ovarian cancer or fallopian tube cancer at any age;
  • of Ashkenazi Jewish descent;
  • have 2 or more blood relatives diagnosed with breast cancer;
  • +30 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

H. Lee Moffitt Cancer Center and Research Institute

Tampa, Florida, 33612, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsTriple Negative Breast NeoplasmsHereditary Breast and Ovarian Cancer Syndrome

Interventions

Videotape Recording

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesOvarian NeoplasmsEndocrine Gland NeoplasmsNeoplastic Syndromes, HereditaryOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System DiseasesGonadal Disorders

Intervention Hierarchy (Ancestors)

Tape RecordingAudiovisual AidsEducational TechnologyTechnologyTechnology, Industry, and AgricultureTelevision

Study Officials

  • Susan Vadaparampil

    H. Lee Moffitt Cancer Center and Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2015

First Posted

May 22, 2015

Study Start

July 27, 2012

Primary Completion

July 11, 2016

Study Completion

July 12, 2019

Last Updated

November 8, 2019

Record last verified: 2019-11

Locations